https://orcid.org/0000-0001-9836-1696
References
- Pharmacists ASoH-S. ASHP statement on the pharmacist’s role in clinical pharmacokinetic monitoring. Am J Health-Syst Pharm. 1998;55(16):1726–7.
- Kang J-S, Lee M-H. Overview of therapeutic drug monitoring. Korean J Intern Med. 2009;24(1):1.
- Bond C, Raehl CL. 2006 national clinical pharmacy services survey: clinical pharmacy services, collaborative drug management, medication errors, and pharmacy technology. Pharmacotherapy J Hum Pharmacol Drug Therapy. 2008;28(1):1–13.
- LeBlanc JM, Seoane-Vazquez EC, Arbo TC, Dasta JF. International critical care hospital pharmacist activities. Intensive Care Med. 2008;34(3):538–542.
- Jurado LV, Steelman JD. The role of the pharmacist in the intensive care unit. Crit Care Nurs Q. 2013;36(4):407–414.
- Kheir N, Awaisu A, Gad H, Elazzazy S, Jibril F, Gajam M. Clinical pharmacokinetics: perceptions of hospital pharmacists in Qatar about how it was taught and how it is applied. Int J Clin Pharm. 2015;37(6):1180–1187.
- Marquis KA, DeGrado JR, Labonville S, Kubiak DW, Szumita PM. Evaluation of a pharmacist-directed vancomycin dosing and monitoring pilot program at a tertiary academic medical center. Ann Pharmacother. 2015;49(9):1009–1014.
- Kawamura K, Son D, Nakashima M, Utsumi M. Elucidating obstructive factors for IPW from the pharmacist position in clinical practice. Yakugaku zasshi J Pharm Soc Japan. 2015;135(1):123–129.
- Alsultan MS, Mayet AY, Khurshid F, Al-Jedai AH. Hospital pharmacy practice in Saudi Arabia: drug monitoring and patient education in the Riyadh region. Saudi Pharm J. 2013;21(4):361–370.
- McLeod M, Ahmed Z, Barber N, Franklin BD. A national survey of inpatient medication systems in English NHS hospitals. BMC Health Serv Res. 2014;14(1):1–11.
- Alhameed AF, Khansa SA, Hasan H, Ismail S, Aseeri M. Bridging the gap between theory and practice; the active role of inpatient pharmacists in therapeutic drug monitoring. Pharmacy. 2019;7(1):20.
- Ratanajamit C, Kaewpibal P, Setthawacharavanich S, Faroongsarng D. Effect of pharmacist participation in the health care team on therapeutic drug monitoring utilization for antiepileptic drugs. J Med Assoc Thai. 2011;92(11):1500.
- Salem M, Khalil A, Mohamed A, Elmasoudi A. Evaluation of vancomycin initial trough levels in children: a 1-year retrospective study. SAGE Open Med. 2020;8:2050312120951058.
- Rybak M, Lomaestro B, Rotschafer JC, Moellering R, Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66(1):82–98.
- McCluggage L, Lee K, Potter T, Dugger R, Pakyz A. Implementation and evaluation of vancomycin nomogram guidelines in a computerized prescriber-order-entry system. Am J Health Syst Pharm. 2010;67(1):70–75.
- Damfu N, Aseeri M, Davis A, Hasan H, Ismail S. The impact of pharmacist led vancomycin order set implementation in a computerized-prescriber-order-entry (CPOE) system at a tertiary care centre: a quasi experimental study. J Pharmacovigil. 2016;4:219.